Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

The Romans created a remarkably organized and well-structured society. A big part of that was writing; they wrote often, and ...

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Isomorphic Labs is nearing human clinical trials for drugs developed using AI. Isomorphic helps pharma partners with their drug development programs while also working on its own internal drug ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO By Sarah Jackson Andrew Brookes/Getty Images Feb 26, 2024, 1:11 PM PT ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll ...

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...